Pfizer Pays $11.6 Billion for Drug-Maker in Its Biggest Deal Since 2016

by Madeline Garfinkle • May 10, 2022 • 0 Comments

Pfizer announced it will buy migraine drug maker Biohaven for about $11.6 billion – in cash.